- Home
- XGN vs MED Comparison
XGN vs MED Comparison
Compare XGN & MED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XGN
- MED
- Stock Information
- Founded
- XGN 2002
- MED 1980
- Country
- XGN United States
- MED United States
- Employees
- XGN N/A
- MED N/A
- Industry
- XGN Medical Specialities
- MED Packaged Foods
- Sector
- XGN Health Care
- MED Consumer Staples
- Exchange
- XGN Nasdaq
- MED Nasdaq
- Market Cap
- XGN 138.3M
- MED 152.3M
- IPO Year
- XGN 2019
- MED N/A
- Fundamental
- Price
- XGN $9.74
- MED $14.01
- Analyst Decision
- XGN Strong Buy
- MED Hold
- Analyst Count
- XGN 5
- MED 1
- Target Price
- XGN $12.40
- MED $16.50
- AVG Volume (30 Days)
- XGN 222.1K
- MED 158.3K
- Earning Date
- XGN 11-11-2025
- MED 11-03-2025
- Dividend Yield
- XGN N/A
- MED N/A
- EPS Growth
- XGN N/A
- MED N/A
- EPS
- XGN N/A
- MED 0.33
- Revenue
- XGN $58,862,000.00
- MED $480,449,000.00
- Revenue This Year
- XGN $22.09
- MED N/A
- Revenue Next Year
- XGN $13.62
- MED N/A
- P/E Ratio
- XGN N/A
- MED $42.34
- Revenue Growth
- XGN 3.89
- MED N/A
- 52 Week Low
- XGN $2.38
- MED $11.57
- 52 Week High
- XGN $10.34
- MED $21.98
- Technical
- Relative Strength Index (RSI)
- XGN 56.30
- MED 53.49
- Support Level
- XGN $9.55
- MED $13.37
- Resistance Level
- XGN $10.28
- MED $14.10
- Average True Range (ATR)
- XGN 0.37
- MED 0.40
- MACD
- XGN -0.08
- MED 0.01
- Stochastic Oscillator
- XGN 34.94
- MED 62.14
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
About MED MEDIFAST INC
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.